BIOS

BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BIOS was delisted on the 6th of October, 2023.

Back to rankings

56 hedge funds and large institutions have $173M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$99K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.2M
2
+$11.7M
3
+$9.88M
4
Millennium Management
Millennium Management
New York
+$9.78M
5
Goldman Sachs
Goldman Sachs
New York
+$8.15M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$15.2M
2
$11.7M
3
$9.88M
4
$9.78M
5
$8.15M
6
$7.56M
7
$7.41M
8
$6.42M
9
$6.17M
10
$6.1M
11
$5.34M
12
$4.94M
13
$4.94M
14
$4.94M
15
$4.94M
16
$4.94M
17
$3.95M
18
$3.76M
19
$3.46M
20
$2.71M
21
$2.68M
22
$2.47M
23
$2.47M
24
$2.47M
25
$2.47M
1
2 3